Novitium Pharma recalls Novitium Pharma — Ranitidine Hydrochloride Capsules 150 mg and 300 mg
- Recall date
- October 25, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Novitium Pharma, Novitium Pharma
Why it was recalled
May contain N-Nitrosodimethylamine (NDMA) — Ingredient Level
What was recalled
Ranitidine Hydrochloride Capsules 150 mg and 300 mg
Read the official recall notice →
Get recall alerts
Free email alert whenever Novitium Pharma has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Novitium Pharma, Novitium Pharma